Purpose of Technology:
Phototherapy is used to treat jaundice in newborns, and to prevent severe hyperbilirubinemia, and its complications. The lights in phototherapy units emit photons that alter the structure of the bilirubin molecule, which can then be excreted in bile or urine. Fiberoptic phototherapy (FPT) systems are light-emitting pads or blankets that are placed under or wrapped around an infant as an adjunct or alternative to standard phototherapy (SPT) delivered by overhead lights.
How does FPT compare with SPT for the treatment of hyperbilirubinemia in term infants?
Is FPT an effective adjunct to SPT for the treatment of hyperbilirubinemia in term infants?
Is FPT safe in term infants?
Have definitive patient selection criteria been established for the use of FPT?
If you have a Hayes login, click here to view the full report on the Knowledge Center.